Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide + WBRT vs WBRT for Brain Metastasis from NSCLC
NCT00076856Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Mar 2004
- Primary completion
- Mar 2006
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of temozolomide in brain metastases, sponsored by Merck & Co.. Started Mar 2004; status: completed.
02
Drugs
temozolomide
03
Conditions
brain metastases
Beyond the preview
Go deeper on NCT00076856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00076856.